✦ LIBER ✦

Changes over time of extracellular domain of HER2 (ECD/HER2) serum levels have prognostic value in metastatic breast cancer

✍ Scribed by Vivien H. C. Bramwell; Gordon S. Doig; Alan B. Tuck; Sylvia M. Wilson; Katia S. Tonkin; Anna Tomiak; Francisco Perera; Theodore A. Vandenberg; Ann F. Chambers

Publisher: Springer US
Year: 2008
Tongue: English
Weight: 216 KB
Volume: 114
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-008-0033-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The prognostic and predictive values of

The prognostic and predictive values of circulating HER-2/neuextracellular domain in patients with metastatic breast cancer

✍ Maysa M. Abu-Khalaf; Lyndsay Harris 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 135 KB

Serum HER2/ECD value in stage I and II e

Serum HER2/ECD value in stage I and II early breast cancer – need of a lower cut-off?

✍ Sasha Badzek; Vesna Lesko Kelovic; Stjepko Plestina; Ines Humar; Zoran Veir; Zel 📂 Article 📅 2011 🏛 Springer Vienna 🌐 English ⚖ 511 KB

High circulating HER2 extracellular doma

High circulating HER2 extracellular domain levels correlate with reduced efficacy of an aromatase inhibitor in hormone receptor-positive metastatic breast cancer: A confirmatory prospective study

✍ Ramon Colomer; Antonio Llombart-Cussac; Belen Lloveras; Manuel Ramos; Jose I. Ma 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB

## Abstract ## BACKGROUND. In this specifically designed, prospective study, the authors addressed the predictive value of circulating levels of the extracellular domain (ECD) of HER2 in patients with metastatic breast cancer who were treated with letrozole. ## METHODS. Two hundred twenty‐six pa